DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB17291
| null |
YS-ON-001
| null | null |
Polyinosinic-polycytidylic acid/inactivated rabies virus | Yivyka
| null |
DB17292
| null |
G305
| null | null |
G305
| null |
DB17293
| null |
Hiltonol
|
59789-29-6
|
7KYP9TKT70
|
5'-cytidylic acid, homopolymer, complex with 5'-inosinic acid homopolymer (1:1), compd. with cellulose carboxymethyl ether and l-lysine homopolymer | 5'-inosinic acid, homopolymer, complex with 5'-cytidylic acid homopolymer (1:1), compd. with cellulose carboxymethyl ether and l-lysine homopolymer | L-lysine, homopolymer, compd. with cellulose carboxymethyl ether and 5'-inosinic acid homopolymer complex with 5'-cytidylic acid homopolymer | Poly iclc | Poly-IC with poly-lysine | Poly-ICLC | Poly(ICLC) | polyinosinic-polycytidilic acid (Poly-ICLC)
| null |
DB17294
| null |
Pixofisiran
|
1152798-48-5
|
O5QC3YP0M7
|
Cotsiranib tgf-.beta.1 si-rna free acid component | Rna, (a-g-a-a-g-u-u-g-g-c-a-u-g-g-u-a-g-c-c-c-u-u-g-g-g), complex with rna (c-c-c-a-a-g-g-g-c-u-a-c-c-a-u-g-c-c-a-a-c-u-u-c-u) (1:1) | Stp-705 component tgf-.beta.1 si-rna free acid | Tgf-.beta.1 si-rna free acid component of cotsiranib
| null |
DB17295
| null |
Lixadesiran
|
1152798-49-6
|
P3CNL1GL6K
|
Rna, (a-c-a-u-c-a-u-c-a-g-a-c-c-a-g-g-c-a-c-c-a-g-a-c-c), complex with rna (g-g-u-c-u-g-g-u-g-c-c-u-g-g-u-c-u-g-a-u-g-a-u-g-u) (1:1) | Stp-705 component anti-cox2 si-rna free acid
| null |
DB17296
| null |
Gebasaxturev
|
2122169-83-7
|
4B57CWT710
|
Coxsackievirus A21 | Enterovirus human enterovirus C serogroup coxsackievirus serotype A21 | Human coxsackievirus A21
| null |
DB17297
| null |
Enitociclib
|
1610408-97-3
|
1255AT22ZJ
|
2-pyridinamine, 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-n-(4-(((s(s))-s-methylsulfonimidoyl)methyl)-2-pyridinyl)-
|
YZCUMZWULWOUMD-NDEPHWFRSA-N
|
DB17298
| null |
Disufenton
|
168021-77-0
|
797K01YF1M
|
1,3-benzenedisulfonic acid, 4-(((1,1-dimethylethyl)oxidoimino)methyl)- | 2,4-disulfonyl-.alpha.-phenyl-tert-butylnitrone | 4-(((1,1-dimethylethyl)imino)methyl)benzene-1,3-disulfonate n-oxide | 4-(((1,1-dimethylethyl)imino)methyl)benzene-1,3-disulphonate n-oxide | 4-(((1,1-dimethylethyl)oxidoimino)methyl)-1,3-benzenedisulfonic acid | 4-tert-butyliminomethyl)benzene-,3-disulfonate n-oxide | 4-tert-butyliminomethyl)benzene-,3-disulphonate n-oxide
|
OVTCHWSLKGENKP-GHXNOFRVSA-N
|
DB17299
| null |
p-Toluenesulfonamide
|
70-55-3
|
I8266RI90M
|
4-methylbenzenesulfonamide | 4-toluenesulfonamide | Benzenesulfonamide, 4-methyl- | P-methylbenzenesulfonamide | P-toluenesulfonylamide | P-tosylamide | Para-toluenesulfonamide | Tolbutamide impurity a | Toluene-4-sulphonamide | Toluenesulfonamide, p-
|
LMYRWZFENFIFIT-UHFFFAOYSA-N
|
DB17300
| null |
Tyroserleutide
|
138168-48-6
|
L9TIM50J8N
|
L-leucine, l-tyrosyl-l-seryl- | L-tyrosine-l-serine-l-leucine
|
MQGGXGKQSVEQHR-KKUMJFAQSA-N
|
DB17301
| null |
Tavokinogene telseplasmid
|
1971880-37-1
|
MF4P7VQ2K8
|
Dna plasmid containing genes coding for the human interleukin 12 (il-12) p35 and p40 subunits that are separated by an internal ribosomal entry site (ires) and under the control of a single cytomegalovirus (cmv) promoter | Dna plasmid encoding interleukin-12 ino-9012 | DNA Plasmid Vector encoding IL-12 (pUMVC3-hIL-12-NGVL331) | Pumvc3-hil | pUMVC3-hIL-12-NGVL331
| null |
DB17302
| null |
SNS01-T
| null | null | null | null |
DB17303
| null |
Leuvectin
| null | null |
DNA-lipid complex (DMRIE/DOPE)/plasmid vector (VCL-1102, Vical) expressing human interleukin-2
| null |
DB17304
| null |
Doranidazole
|
149838-23-3
|
911XR034RX
|
(2rs,3sr)-3-((2-nitroimidazol-1-yl)methoxy)butane-1,2,4-triol | 1,2,4-butanetriol, 3-((2-nitro-1h-imidazol-1-yl)methoxy)-, (2r,3s)-rel-
|
FIITXXIVUIXYMI-RQJHMYQMSA-N
|
DB17305
| null |
MV-NB-02
| null | null |
GD2-GD3 Vaccine | MV Neuro
| null |
DB17306
| null |
Metavert
|
1841125-91-4
|
IZB8PZ86FH
|
Benzamide, n-hydroxy-4-(5-((4-methoxyphenyl)amino)-1,3,4-oxadiazol-2-yl)- | N-hydroxy-4-(5-((4-methoxyphenyl)amino)-1,3,4-oxadiazol-2-yl)benzamide
|
TWABKXHHSQCZPI-UHFFFAOYSA-N
|
DB17307
| null |
IKT-001Pro
| null |
WQJ8L8YJ7U
|
Methanesulfonate-1-sec-butoxycarbonyloxymethyl-1-methyl-4-{4-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenylcarbamoyl]-benzyl}-piperazin-1-ium
| null |
DB17308
| null |
Laurocapram
|
59227-89-3
|
1F3X9DRV9X
|
1-dodecylazacycloheptan-2-one | 1-dodecylhexahydro-2h-azepin-2-one | 1-n-dodecylazacycloheptan-2-one | 2h-azepin-2-one, 1-dodecylhexahydro- | Azone | N-dodecyl-.epsilon.-caprolactam
|
AXTGDCSMTYGJND-UHFFFAOYSA-N
|
DB17309
| null |
Minnelide
|
1254702-87-8
|
1CIV2UMO40
|
14-o-phosphonooxymethyltriptolide disodium salt | Trisoxireno(4b,5:6,7:8a,9)phenanthro(1,2-c)furan-1(3h)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-8b-methyl-6a-(1-methylethyl)-6-((phosphonooxy)methoxy)-, sodium salt (1:2), (3bs,4as,5ar,6r,6as,7as,7bs,8as,8bs)-
|
ZHBJMVNZRZUQEP-KIKMAQITSA-L
|
DB17310
| null |
Heme arginate
|
100438-92-4
|
R1B526117P
|
Haem arginate
| null |
DB17311
| null |
Hepcortespenlisimut-L
| null | null |
Hepko-V5
| null |
DB17312
| null |
Dotamtate Pb-212
| null |
E9N7QV53AK
|
212Pb-dotamtate | Alphamedix | Dotamtate lead Pb-212 | Lead-212 dotamtate
|
XWRQOPLCTVHUPG-DGSPUKEMSA-L
|
DB17313
| null |
CAR BCMA-CS1
| null | null |
BCMA-CS1 cCAR T cell therapy
| null |
DB17314
| null |
KTH-222
| null | null |
Leu-Lys-Gly-Gln-Leu-Arg-Cys-Ile | NH2-LKGQLRCI-C02H
| null |
DB17315
| null |
Leukocyte interleukin
| null | null |
BC-IL
| null |
DB17316
| null |
Liposomal N-acetylglucosminyl-N-acetylmuramly-L-Ala-D-isoGln-L-Ala-gylceroldipalmitoyl
| null | null |
Liposome-incorporated DTP-GDP
| null |
DB17317
| null |
Belzupacap Sarotalocan
|
2390462-37-8
|
DK0ZGA5Y2R
|
Belzupacap serotalocan | Human papillomavirus virus-like particles conjugated with ir700 dye au-011 | Light-activated au-011 | Viral nanoparticle conjugates au-011
| null |
DB17318
| null |
TPIV 200
| null | null |
TPIV-200 | TPIV200 | TPIV200/huFR-1
| null |
DB17319
| null |
Aroplatin
|
114488-24-3
|
J7M4Z2D183
|
cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane-Pt (II) | L-NDDP | Liposomal-cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane-Pt (II)
| null |
DB17320
| null |
Prexigebersen
|
202484-91-1
|
8W1O4Y961B
|
Dna, d(a-t-a-t-t-t-g-g-c-g-a-t-g-g-c-t-t-c) | L-grb-2 antisense | Liposomal grb2 antisense oligonucleotide | Liposome-incorporated grb2 antisense oligodeoxynucleotide
| null |
DB17321
| null |
MEM136
| null | null | null | null |
DB17322
| null |
BI-836826
| null |
LB090AB8DB
|
ANTI-CD37 MONOCLONAL ANTIBODY BI 836826 | BI 836826
| null |
DB17323
| null |
CRS-207
| null |
JJX4JHS4PO
|
Listeria monocytogenes strain attenuated strain CRS-207 | Live-attenuated Listeria monocytogenes actA/inlB/human mesothelin (hMeso) Strain hMeso38
| null |
DB17324
| null |
Listeria monocytogenes
| null |
3O44K14A86
|
Bacterium monocytogenes hominis whole | Bacterium monocytogenes whole | Listeria monocytogenes whole
| null |
DB17325
| null |
ADXS-31164
| null | null |
ADXS 31164 | ADXS-HER2 construct vaccine | ADXS31164
| null |
DB17326
| null |
Delolimogene mupadenorepvec
|
2061938-98-3
|
3ZQ57V6YWZ
|
Dna (synthetic human adenovirus 5/35 vector load703 human cd137 ligand and trimerized membrane-bound isoleucine zipper-containing human cd40 ligand-specifying)
| null |
DB17327
| null |
Zalsenertant tetraxetan lutetium Lu-177
| null |
WH9EXQ390Z
|
177Lu-3BP-227 | 177Lu-DOTA-3BP-227 | 177Lu-DOTA-IPN01087 | 177Lu-IPN01087 | Lutetium Lu 177 DOTA-3BP-227 | Lutetium Lu 177 DOTA-IPN01087 | Lutetium Lu 177 zalsenertant tetraxetan
| null |
DB17328
| null |
RAD 502
| null | null |
Lutetium-177 labeled humanized monoclonal antibody targeting leucine rich repeat containing 15 (LRRC15) | Radiolabelled DUNP19
| null |
DB17329
| null |
Eltrapuldencel-T
| null |
M2LBQ7RN2X
|
Autologous dendritic cells loaded with antigen from self-renewing, proliferating autologous irradiated tumour cells, in a solution of granulocyte-macrophage colony stimulating factor (GM-CSF)
| null |
DB17330
| null |
Onamelatucel-L
| null | null | null | null |
DB17331
| null |
Imvotamab
| null | null | null | null |
DB17332
| null |
Inalimarev
|
685563-13-7
| null | null | null |
DB17333
| null |
Falimarev
|
685563-14-8
| null | null | null |
DB17334
| null |
Indium In-111 altumomab pentetate
|
156586-92-4
|
AT2NU9VQ6M
| null | null |
DB17335
| null |
Indium-111 Pentetreotide
|
139096-04-1
|
M312JJ6Z32
| null | null |
DB17336
| null |
IMGN779
| null |
YE6R3UY9IV
| null | null |
DB17337
| null |
IMGN632
| null | null |
Indolino-benzodiazepine compound (sulfonated DGN549-C) conjugated to the humanized anti-CD123 monoclonal antibody (G4723A)
| null |
DB17338
| null |
MGN-4893
| null | null |
MGN 4893 | MGN4893
| null |
DB17339
| null |
Maveropepimut-S
| null | null |
DPX-Survivac | Maveropepimut S | MVP-S
| null |
DB17340
| null |
ENB-003
| null | null |
ENB 003 | ENB003 | sodium bispiperidine-carboxamido-dimethylpenatnamido-methoxycarbonyl-indol-propanamidohexanoate
| null |
DB17341
| null |
NC-6300
| null |
RQU6X0IM9R
| null | null |
DB17342
| null |
Trimethyltetradecylammonium
|
10182-92-0
|
Y3IR7RCT6J
|
1-tetradecanaminium, n,n,n-trimethyl- | Ammonium, trimethyltetradecyl- | Myristyltrimethylammonium | Tetradecyltrimethylammonium | Tetradonium | Tetradonium cation | Tetradonium ion
|
GLFDLEXFOHUASB-UHFFFAOYSA-N
|
DB17343
| null |
ICG-136
| null | null |
123b-33bcCAR | CD123-CD33cCAR T-cells | ICG 136 | ICG136 | ICG136:CD123-CD33cCAR T-cells
| null |
DB17344
| null |
ICG-140
| null | null | null | null |
DB17345
| null |
Bizaxofusp
|
1236019-35-4
|
FRY3MOL2QU
|
Il-4 pseudomonas toxin fusion protein (il-4(38-37)-pe38kdel) | Il4-pseudomonas exotoxin fusion protein mdna55 | IL4(38-37)-PE38KDEL
| null |
DB17346
| null |
LSTA1
|
1392278-76-0
|
Z8MXU5GH4Q
|
Internalized-arginylglycylaspartic acid cyclic peptide | L-cysteine, l-cysteinyl-l-arginylglycyl-l-.alpha.-aspartyl-l-lysylglycyl-l-prolyl-l-.alpha.-aspartyl-, cyclic (1->9)-disulfide
| null |
DB17347
| null |
MORAb-066
| null | null |
MORAb 066
| null |
DB17348
| null |
TNT-1
| null | null | null | null |
DB17349
| null |
Cibisatamab
|
2101242-53-7
|
ZAM5J1ATF2
|
Anti-cea/cd3 bispecific antibody ro6958688 | Cea cd3 tcb | CEA TCB | Humanized immunoglobulin g1 (igg1) t-cell bispecific (tcb) antibody targeting carcinoembryonic antigen (cea) and cd3 epsilon chain (cd3e) on t-cells
| null |
DB17350
| null |
AIC100
| null | null | null | null |
DB17351
| null |
CVac
| null | null |
Autologous dendritic cells pulsed with recombinant human fusion protein (MUCIN1 and Glutathione S Transferase) coupled to oxidized polymannose
| null |
DB17352
| null |
WT-1 A1
|
852243-39-1
|
V4JB309K8X
|
L-leucine, l-tyrosyl-l-methionyl-l-phenylalanyl-l-prolyl-l-asparaginyl-l-alanyl-l-prolyl-l-tyrosyl- | Tyr-met-phe-pro-asn-ala-pro-tyr-leu
|
IBNSYSWDJJQKSY-PJYANRIDSA-N
|
DB17353
| null |
WT-1 122 long
|
952720-86-4
|
8ER98W0K2C
|
Ser-gly-gln-ala-tyr-met-phe-pro-asn-ala-pro-tyr-leu-pro-ser-cys-leu-glu-ser
| null |
DB17354
| null |
WT-1 427 long
|
935395-33-8
|
WYT2ZC05X2
|
Arg-ser-asp-glu-leu-val-arg-his-his-asn-met-his-gln-arg-asn-met-thr-lys-leu
| null |
DB17355
| null |
WT-1 331 long
|
935395-34-9
|
4OLC0A0F4I
|
Pro-gly-cys-asn-lys-arg-tyr-phe-lys-leu-ser-his-leu-gln-met-his-ser-arg-lys-his-thr-gly
| null |
DB17356
| null |
OBI-999
| null | null |
Humanized Anti-Globo H Monoclonal Antibody Monomethyl Auristatin E Conjugate | OBI 999 | OBI999
| null |
DB17357
| null |
AMG 424
| null | null |
AMG-424 | AMG424 | Humanized Bi-Specific Xmab(R) T Cell Recruiting Antibody Construct Directed Against Cd3 And Cd38
| null |
DB17358
| null |
STM-217
| null |
7G4D2B5AC8
|
Soluble receptor fused to part of an antibody that is designed to block the growth factor activin a | STM 217 | STM217
| null |
DB17359
| null |
Ocaratuzumab
|
1169956-08-4
|
NTY9893GD0
|
Immunoglobulin G1, anti-(human B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1, Bp35, leukocyte surface antigen Leu-16, membrane-spanning 4-domains subfamily A member 1))
| null |
DB17360
| null |
TALL-104
| null | null |
Human major histocompatibility complex (MHC) non-restricted T-cell line 104 | TALL 104 | TALL104
| null |
DB17361
| null |
Autologous DNP-conjugated tumour vaccine
| null | null |
DNP-VACC | M Vax | M-Vax | MVax
| null |
DB17362
| null |
Obecabtagene autoleucel
| null |
760HJB0YRD
|
Obe-cel
| null |
DB17363
| null |
AMG-119
| null | null | null | null |
DB17364
| null |
AUTO3
| null | null |
AUTO 3
| null |
DB17365
| null |
SynKIR-110
| null | null |
SynKIR-meso | SynKIR-meso CAR-T cells
| null |
DB17366
| null |
MB-102 CD123 CAR
| null | null | null | null |
DB17367
| null |
Gavocabtagene autoleucel
| null |
NP6CFH3G8H
|
Gavo-cel
| null |
DB17368
| null |
LioCyx-M004
| null | null |
mRNA HBV/TCR T-cells
| null |
DB17369
| null |
RR001
| null | null |
autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand
| null |
DB17370
| null |
TBX-3400
| null | null |
TBX 3400
| null |
DB17371
| null |
P-BCMA-101
| null | null |
Autologous T-cells transfected with PiggyBac transposon plasmid vector expressing B-cell maturation antigen (CAR-T cells)
| null |
DB17372
| null |
Human Recombinant Bone Morphogenetic Protein 4
| null |
08RQ4CQ601
|
HRBMP4 | R-HBMP4 | RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 4
| null |
DB17373
| null |
BB 21217
| null | null | null | null |
DB17374
| null |
Tabituximab barzuxetan
|
1612758-88-9
|
3K3IOQ7Q1K
| null | null |
DB17375
| null |
Ferritarg P
| null | null |
Yttrium (90Y) Antiferritin Polyclonal Antibodies
| null |
DB17376
| null |
Zanolimumab
|
652153-01-0
|
HG3L8885M0
|
Humax-cd4 | IMMUNOGLOBULIN, ANTI-(HUMAN CD4 ANTIGEN) (HUMAN MONOCLONAL 6G5 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL 6G5 LIGHT CHAIN, DIMER
| null |
DB17377
| null |
Bersanlimab
|
1987854-08-9
|
MP3N1L4OR6
|
Anti-icam-1 monoclonal antibody bi-505 | Immunoglobulin g1-lambda, anti-(homo sapiens icam1(intercellular adhesion molecule 1, icam-1, cd54)), human monoclonal antibody | Immunoglobulin g1, anti-(human intercellular adhesion molecule icam-1) (human monoclonal bi-505 .gamma.1-chain), disulfide with monoclonal bi-505 light-chain, dimer
| null |
DB17378
| null |
MVR-T3011
| null | null |
T3011
| null |
DB17379
| null |
(R)-Gossypol
|
90141-22-3
|
8DY2X8LXW4
|
(-)-Gossypol | (r)-2,2'-bis(8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene) | Gossypol r-form | Gossypol, (r)- | Gossypol, r- | R-(-)-gossypol
|
QBKSWRVVCFFDOT-UHFFFAOYSA-N
|
DB17380
| null |
Saposin C
| null |
2N62LTC861
|
BXQ-350 | SAPOSIN C (NON-GLYCOSYLATED) | SAPOSIN C RECOMBINANT
| null |
DB17381
| null |
Nadofaragene firadenovec
|
1823059-12-6
|
0OOS09O1FH
|
Instiladrin | Nadofaragene firadenovec | Nadofaragene firadenovec-vncg | RAD-IFN | RAD-IFN-2B | Replication-deficient adenovirus type 5 (ad5) vector encoding the human interferon alpha 2 (ifna2, interferon alpha-2b) gene under the control of the cytomegalovirus (cmv) immediate-early enhancer/promoter | SCH-209702/SCH-721015
| null |
DB17382
| null |
AUM-601
| null | null |
AUM 601 | AUM601 | CHC 2014 | HL 5101 | NOV 1601
| null |
DB17383
| null |
FN-1501
|
1429515-59-2
|
6MC966B505
|
4-((7h-pyrrolo (2,3-d)pyrimidin-4-yl)amino)-n-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1h-pyrazole-3-carboxamide
|
VXLAKHWYGRKCGI-UHFFFAOYSA-N
|
DB17384
| null |
Tinengotinib
|
2230490-29-4
|
WZ9TJ0L9Y8
|
4-(5-(2-Chlorophenyl)-3-Methyl-2,10-Dihydropyrazolo[4,3-B] Pyrido[4,3-E][1,4]Diazepin-8-Yl) Morpholine | 5-(2-chlorophenyl)-3-methyl-8-(morpholin-4-yl)-1,10-dihydropyrazolo[4,3-b]pyrido[4,3-e][1,4]diazepine | Pyrazolo(4,3-b)pyrido(4,3-e)(1,4)diazepine, 5-(2-chlorophenyl)-1,2-dihydro-3-methyl-8-(4-morpholinyl)-
|
DQFCVOOFMXEPOC-UHFFFAOYSA-N
|
DB17385
| null |
Lipotecan
|
1432468-79-5
|
D47234N30N
|
Lipothecan free base | Propanoic acid, 2-(((2,4,5,7-tetranitro-9h-fluoren-9-ylidene)amino)oxy)-, (4s)-10-((dimethylamino)methyl)-4-ethyl-3,4,12,14-tetrahydro-9-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-4-yl ester
|
JCCCLGDYMMTBPM-HXDHBHDHSA-N
|
DB17386
| null |
Xenon Xe-129
|
13965-99-6
|
9C7571UDT5
|
Xenon xe-129m | Xenon-129m | Xenon, isotope of mass 129 | Xenon, isotope of mass 129m(8.88 d) | Xenon, xe-129m
|
FHNFHKCVQCLJFQ-YPZZEJLDSA-N
|
DB17387
| null |
BR101801
| null | null |
4-[[(1S)-1-(4,8-dichloro-1-oxo-2-phenylisoquinolin-3-yl)ethyl]amino]-8H-pyrido[2,3-d]pyrimidin-5-one
| null |
DB17388
| null |
4-{[(2R,3S,4R,5S)-4-(4-Chloro-2-Fluoro-Phenyl)-3-(3-Chloro-2-Fluoro-Phenyl)-4-Cyano-5-(2,2-Dimethyl-Propyl)-Pyrrolidine-2-Carbonyl]-Amino}-3-Methoxy-Benzoic Acid
|
1219089-31-2
| null | null | null |
DB17389
| null |
WTx-Bortezomib
| null | null | null | null |
DB17390
| null |
Vinblastine N-oxide
|
61936-68-3
|
PN45E4NV2N
|
Vinblastine N-oxide
|
JJNRGDILJOBAEK-VXTPCRFLSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.